ARCHIVE SEARCH
      -OR-  
 
  NEWS CHANNELS
Fitness News
Asthma Allergy News
 > Diabetes News
Women's Health News
Men's Health News

  MY NEWS
Personal Archive
My Account

  ABOUT THIS NEWSFEED
About Us
Advertise With Us
Feed Your Site
Contact Us


Site Map
RSS News Feed 

  Website development & hosting
   by Cyber Software Solutions

 
In Diabetes Patients, QOL Similar Two Years After CABG, PCI
FREEDOM trial substudy looks at functional status after revascularization for multi-vessel disease

WEDNESDAY, Oct. 16 (HealthDay News) -- Among patients with diabetes undergoing revascularization for multi-vessel coronary artery disease (CAD), coronary artery bypass graft (CABG) surgery provides better intermediate health status and quality of life (QOL) than percutaneous coronary intervention (PCI) with drug-eluting stents, but the differences are small and transient, according to research published in the Oct. 16 issue of the Journal of the American Medical Association.

Mouin S. Abdallah, M.D., of Saint Luke's Mid America Heart Institute in Kansas City, Mo., and colleagues assessed the effects of CABG (947 patients) versus PCI (953 patients) on health status and QOL in patients with diabetes and multi-vessel CAD.

At two-year follow-up, the researchers observed significantly greater mean differences in treatment benefit in scores for angina frequency (1.3 points), physical limitations (4.4 points), and QOL subscales (2.2 points) with CABG versus PCI. After two years, patient outcomes were similar in both groups.

"Beyond two years, there were no consistent differences in any health status or quality-of-life domains between the CABG and PCI strategies," the authors write.

Several authors disclosed financial ties to the pharmaceutical and/or medical device industry, which provided funding, study drugs, and stents.

Abstract
Full Text (subscription or payment may be required)



Copyright © 2013 HealthDay. All rights reserved.


Back to Top Stories
  GOOGLE ADS